Nations Financial Group’s Zomedica Corp. ZOM Stock Holding History

Nations Financial Group’s Portfolio ZOM Stock Details ZOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-26,000	Closed	-$9K	–	571
2022 Q1	$9K	Hold	26,000	–	–	﹤0.01%	516
2021 Q4	$8K	Hold	26,000	–	–	﹤0.01%	469
2021 Q3	$14K	Hold	26,000	–	–	﹤0.01%	434
2021 Q2	$22K	Hold	26,000	–	–	﹤0.01%	399
2021 Q1	$41K	Buy	+26,000	New	+$42.5K	0.01%	345

Other funds holding ZOM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

PWMG

Pinnacle Wealth Management Group Plymouth, Michigan $214M AUM 20.07% 1-Year Est. Return

Nations Financial Group's ZOM Position: Q2 2022 in Review

Nations Financial Group sold out of Zomedica Corp. (ZOM) in Q2 2022, closing a stake of 26,000 shares — an estimated $9K sold.

Nations Financial Group first reported a position in ZOM in Q1 2021 and held it in 5 quarters. The position peaked at $41K in Q1 2021. 97 funds tracked by Wall St. Rank hold ZOM as of Q2 2022.

Nations Financial Group reported no remaining Zomedica Corp. position as of Q2 2022 after selling out during the quarter.
Nations Financial Group sold 26,000 Zomedica Corp. shares in Q2 2022, an estimated $9K.
Nations Financial Group first reported a position in Zomedica Corp. in Q1 2021 and held it in 5 quarters.
Nations Financial Group's Zomedica Corp. position peaked at $41K in Q1 2021.
97 funds tracked by Wall St. Rank held Zomedica Corp. as of Q2 2022.

Based on Nations Financial Group's 13F filing for Q2 2022, filed 15 Aug 2022.